
-
Apple to invest additional $100 bn in US
-
Trump says likely to meet Putin 'very soon'
-
Major climate-GDP study under review after facing challenge
-
Lebanon's Hezbollah rejects cabinet decision to disarm it
-
Rare 'Hobbit' first edition auctioned for £43,000
-
Sinner lukewarm on expanded Cincinnati format
-
Rested Scheffler ready to tackle US PGA Tour playoffs
-
Sudan says army destroys Emirati aircraft, killing 40 mercenaries
-
White House says Trump open to meeting Putin and Zelensky
-
Grok, is that Gaza? AI image checks mislocate news photographs
-
'Global icon' Son Heung-min joins LAFC from Tottenham
-
In Cuba, Castro's 'influencer' grandson causes a stir
-
Mexican president backs threatened female football referee
-
German great Mueller signs with MLS Whitecaps
-
US government gets a year of ChatGPT Enterprise for $1
-
Egypt sets opening of $1 bn Pyramids museum for Nov 1
-
Prince Harry, African charity row rumbles on as watchdog blames 'all parties'
-
Brazil seeks WTO relief against Trump tariffs
-
Isak told to train alone by Newcastle - reports
-
McDonald's sees US rebound but says low-income diners remain stressed
-
Trump hikes India levy over Russian oil as tariff deadline approaches
-
Swiss president hopes Washington talks avert surprise tariff
-
France wildfire kills one as Spanish resort evacuated
-
Stocks higher with eyes on earnings, US tariff deadline
-
Vonn appoints Svindal as coach ahead of 2026 Olympics
-
Backlash after 'interview' with AI avatar of US school shooting victim
-
Darth Vader's lightsaber could cost you an arm and a leg
-
Swiss president to meet Rubio as surprise tariff hike looms
-
Israel orders army to execute govt decisions on Gaza
-
Italy approves plans for world's longest suspension bridge
-
Arsenal have 'belief' to end trophy drought, says Arteta
-
Putin decree allows Russia to increase greenhouse gas emissions
-
Putin holds 'constructive' talks with US envoy Witkoff ahead of sanctions deadline: Kremlin
-
Liverpool set to cut losses with Nunez move to Saudi: reports
-
Stocks tick up with eyes on earnings, US tariff deadline
-
German broadcast giant backs takeover by Berlusconi group
-
Pro-Trump nationalist becomes Poland's new president
-
Putin meets US envoy Witkoff ahead of sanctions deadline
-
UK watchdog bans Zara ads over 'unhealthily thin' model photos
-
Natural disasters caused $135 bn in economic losses in first half of 2025: Swiss Re
-
Rebuilding in devastated Mariupol under Russia's thumb
-
One dead, nine injured in huge France wildfire
-
German factory orders fall amid tariff, growth woes
-
Turkmenistan's methane-spewing 'Gateway to Hell' loses its anger
-
Markets tick up but traders wary as Trump tariffs temper rate hopes
-
A year on, Ugandans still suffering from deadly garbage collapse
-
Ozempic maker Novo Nordisk posts strong results but competition weighs
-
Prince Harry cleared of 'bullying' in African charity row
-
Taiwan's orchid growers dig in as US tariffs shoot up
-
Cuba activists say detained on anniversary of 1994 anti-Castro protest
CMSC | -0.52% | 22.95 | $ | |
SCU | 0% | 12.72 | $ | |
RBGPF | 1.42% | 76 | $ | |
CMSD | 0.13% | 23.54 | $ | |
BCC | -4.64% | 82.92 | $ | |
NGG | 0.03% | 72.3 | $ | |
SCS | 0.19% | 15.99 | $ | |
GSK | -1.55% | 36.75 | $ | |
RIO | 0.65% | 60.09 | $ | |
RELX | -3.65% | 48.81 | $ | |
BTI | 0.99% | 56.4 | $ | |
RYCEF | 0.9% | 14.48 | $ | |
JRI | 0.6% | 13.34 | $ | |
AZN | -1.2% | 73.6 | $ | |
VOD | 1.77% | 11.3 | $ | |
BCE | -1.33% | 23.25 | $ | |
BP | 0.83% | 33.88 | $ |

Japan firm probing 76 more deaths in supplement scare
Japanese health supplement maker Kobayashi Pharmaceutical said Friday it was probing 76 more deaths possibly linked to its tablets containing red yeast rice, meant to lower cholesterol.
It deepens a scandal that erupted earlier this year when the company said it was looking into five deaths potentially linked to the over-the-counter products after dozens of customers reported kidney problems.
Fermented with a mould culture, red yeast rice, or "beni koji", has been used in food, alcoholic drinks and folk medicines for centuries around East Asia.
"Even if the direct cause of hospitalisation or death was not kidney-related disease, it has become clear that there are a variety of cases, including cases in which beni koji-related products may have caused harm somehow and had some indirect impact," a Kobayashi statement said.
Of the five initial deaths under investigation, the company said it now knows one did not consume red yeast rice.
"We have received 1,656 inquiries from individuals who have sought medical attention, and have 76 cases under investigation over (a causal) connection to the deaths," in addition to the original four, it said.
On March 22, Kobayashi Pharmaceutical said it was recalling three kinds of tablets containing beni koji.
It later said it had detected a potentially toxic acid produced by the mould at one of its factories, and government officials inspected the firm's facilities.
Kobayashi Pharmaceutical is a household name in Japan, offering a wide range of health-related products, and the scandal has been top news in the country.
On Friday, Kobayashi said it would work to identify the exact cause and scope of the health damage -- including whether organs other than kidneys were harmed.
Top government spokesman Yoshimasa Hayashi said Friday that the health ministry had previously ordered the company to file a daily report on its probe, and demanded more details earlier this month after the number of deaths under investigation didn't change.
"But until today, it had not reported the specific number of cases under investigation, and it is extremely regrettable," Hayashi told reporters.
Kobayashi Pharmaceutical has said it also sold red yeast rice to around 50 other firms in Japan and two in Taiwan.
Taiwanese companies preventively recalled 154 products containing red yeast rice in the wake of the scare, the island's health authorities said earlier this year.
T.Zimmermann--VB